Navigation Links
Solos Endoscopy, Inc.'s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
Date:10/14/2009

BOSTON, Oct. 14 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has taken the initial steps to obtain the CE Mark for its Food and Drug Administration (FDA) approved MammoView(TM) line of surgical endoscopy instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU). The entire Solos Endoscopy product line has already received FDA approval for sale within the U.S. and the Company is now working diligently to capture market share within the EEU. According to a 2009 report published by Frost & Sullivan, the EEU represents $94 Billion, or 30%, of the worldwide demand for medical instruments.

Solos Endoscopy is working closely with its manufacturers to ensure all requirements of the Medical Devices Directive (MDD 93/42/EEC) are met. The Company is familiar with the steps that are to be taken to obtain the CE Mark for its MammoView(TM) line of surgical endoscopy instruments, as all of the Company's other medical devices have already obtained the CE Mark. Solos Endoscopy is currently in discussions with several companies, to act as its Authorized Representatives (EC REP) to liaison with its targeted European markets.

"Expanding into the EEU provides unlimited sales opportunities for Solos Endoscopy and our goal is to commence sales, within several European countries, in 2010," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's we
'/>"/>

SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
2. Solos Endoscopy, Inc.s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
5. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
6. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
7. Newly Approved HIV Drug Shows Great Promise
8. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
9. Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
10. Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
11. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Intec Pharma Ltd. (the "Company") (NASDAQ: NTEC ... drugs based on its proprietary Accordion Pill platform technology, ... in the United States of ... the public of $6.00 per ordinary share, before underwriting ... being offered by the Company.  In addition, the Company ...
(Date:8/4/2015)... , Aug. 4, 2015 Concord Medical Services ... leading specialty hospital management solution provider and operator of the ... China , today announced it will release its ... market closes on August 17, 2015. Management will ... day, at 8:00 a.m. EDT on August 18, 2015 (8:00 ...
(Date:8/4/2015)... 4, 2015 BioElectronics Corporation (OTC Pink: ... Pain Therapy medical devices, announced today that its ... 7-day trial device has been published in the ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic ... an assessment.  Chronic pain is ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2
... International, Inc. (Nasdaq: HTWR ; ASX: HIN), ... technologies that are revolutionizing the treatment of advanced heart ... to make an investor presentation at the UBS 2010 ... 12:30 pm EDT.  The conference will be held September ...
... KING OF PRUSSIA, Pa., Sept. 15 ... into a strategic alliance with Campbell Informatics, an integrated ... alliance of Tunnell, a leading life sciences industry consultancy, ... life sciences manufacturers, suppliers and regulators, is designed to ...
Cached Medicine Technology:HeartWare to Present at the UBS 2010 Global Life Sciences Conference 2Tunnell Consulting Forms Strategic Alliance With Ireland-Based Campbell Informatics 2
(Date:8/4/2015)... ... August 04, 2015 , ... Exsurco Medical, ... of Tissue Banks (AATB) as an Affiliate Member. Exsurco Medical finds this ... to save and improve lives by promoting the safety, quality and availability of ...
(Date:8/4/2015)... Raton, FL (PRWEB) , ... August 04, 2015 ... ... diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced ... but has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a ...
(Date:8/4/2015)... ... 04, 2015 , ... Angelina Jolie is in it at age 39. “It” ... Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the ... out of menopause. , Myth #1: Menopause only affects old ladies. – Menopause ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... Rise of Local Food,” scheduled for Nov. 3 – 4, 2015, at UC ... food sustainably, create new businesses, improve food access, and manage resources efficiently against ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... 24/7 ... County, Los Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of ... indicate that 24/7 Care At Home’s agency is well on the path to meeting ...
Breaking Medicine News(10 mins):Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3
... Md., Nov. 6 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... commercializing novel anti-infective products, today,announced that three patents ... the FDA Orange Book on,Oct. 24, 2008, pursuant ... which was,enacted on Oct. 8, 2008., MiddleBrook ...
... Nektar,Therapeutics (Nasdaq: NKTR ) today announced that it ... debt for approximately 48,cents on the dollar, for a ... its financial results for the third quarter and,nine-months ended ... now largely complete," said Nektar,President and CEO Howard W. ...
... Sysmex further expands the value and capabilities ... 6 Sysmex America, Inc. (SAI), a,leading ... today announced the launch of e-Verify(TM), the ... said,John Kershaw, President, Sysmex America, Inc. e-Verify ...
... effects on vitality unclear, scientists say , , THURSDAY, Nov. ... restore the amounts of muscle-linked growth hormone in seniors ... on the therapy also gained muscle mass over the ... that this led to significant improvements in their strength ...
... Ad Campaign Calling for "Health Reform We Can Believe In" ... ... president of Partnership for Prevention said today that President-elect Obama,s call ... health promotion a cornerstone of any health reform effort. Accordingly, the ...
... Third quarter revenues increase 65 percent versus third quarter last ... Conference Call at 4:30 p.m. Eastern Time Today, ... ), the worldwide leader in intravascular temperature,management (IVTM(TM)) therapies for ... progress for the third quarter and,nine months ended September 30, ...
Cached Medicine News:Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Sysmex America to Release e-Verify(TM), Powered By SNCS(TM) 2Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 3Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 5Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 6Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 7
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With tubular base • unit ...
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Medicine Products: